panakés partners

The Universal Remedy In European Medtech Industry

Venture Capital investments in startup and high-growth SMEs in Europe & Israel


About us

Panakes derives from Panacea (Greek Πανάκεια, Panakeia), who was the goddess of Universal remedy, said to have a potion with which she healed the sick.

Panakes Partners is a Venture Capital investor that finances medical companies, early stage startup and SMEs, with extremely promising products and great ambition, in Europe and Israel.

Thanks to our strong entrepreneurial and financial experiences we provide more than capital, and we aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor. We also have strong relationship with selected industrial partners to help companies to accelerate their development.

We seek and help to grow Medtech companies with the potential to have a positive impact on society. We believe such opportunities create the most value for all parties.
From our office in Milan, Panakes is willing to back the smartest entrepreneurs with the best technologies and ideas.


Our Approach

Investment Focus
Investment Focus
  • Medical Device
  • Medical Diagnostics
  • Biotech for in-vitro diagnostics
  • Healthcare-IT
  • Innovative medical services
Our Advantages
Our Advantages
  • Broad Network of Business Contacts and Corporate Relations
  • Deep Domain Expertise
  • Proactive Portfolio Management
  • Strong relationship with selected industrial partners
We are looking for
We are looking for
  • Unique technologies solving medical industry real problem
  • Strong teams with deep knowledge of the industry
  • Clear competitive advantage and sizable market potential
  • Companies in need of capital to accelerate market acceptance


Alessio Beverina linkedin Alessio Beverina mail
Alessio Beverina
Alessio Beverina
Founder and Managing Partner
  • Former Partner at Sofinnova Partners
  • Invested followed and exited over 10 Start-ups & SMEs in Europe
  • Deep knowledge of technology development acquired through several roles at leading Electronics companies and Labs (STM, LETI)
  • Msc in Chemical Engineering @ Politecnico di Milano and MBA ESCP-EAP, Kauffman Fellow
Fabrizio Landi linkedin Fabrizio Landi mail
Fabrizio Landi
Fabrizio Landi
President, Founder and Managing Partner
  • Former Managing Director and General Manager at Esaote
  • Serving as director of several corporate and institutions
  • Deep knowledge of the market acquired through several roles at leading healthcare companies (Bayer, Esaote, Bracco, Menarini)
  • Msc in BioEngineering @ Politecnico di Milano
Diana Saraceni linkedin Matteo Panfilo mail
Diana Saraceni
Diana Saraceni
Founder and Managing Partner
  • Co-Founder & Former Managing Partner at 360 Capital Partners
  • 15 years of Venture Capital experience, invested in a significant number of companies in Italy and all over Europe not only in the medical device sector, and generated several exits as IPO and M&A transactions
  • Strong Knowledge of the Venture Capital community in Italy/Europe
  • Msc in Engineering @ LaSapienza and MBA Luiss University
Barbara Castellano linkedin Barbara Castellano mail
Barbara Castellano
Barbara Castellano
  • Former CEO Techwald
  • Former Director Clinical Affairs, Certifications and Registrations, Quality Assurance CID SpA
  • Former Director Business Development, Heart Valves BU at Sorin
  • Strong Knowledge in the cardiovascular sector
  • Msc in Medicinal Chemistry and Technology @ University of Perugia and MBASDA Bocconi
Alessio Piuma linkedin Alessio Piuma mail
Alessio Piuma
Alessio Piuma
  • Medical Devices Data Manager at A.Demori SPA
  • Researcher at IRCCS Mario Negri – Tissue Engineering Unit
  • MSc in Biomedical Engineering at Politecnico di Milano
Michele Alloni linkedin Michele Alloni mail
Michele Alloni
Michele Alloni
  • MSc in Biomedical Engineering at Politecnico di Milano
Giacomo Piccinini linkedin Giacomo Piccinini mail
Giacomo Piccinini
Giacomo Piccinini
  • MSc in Biomedical Engineering at Politecnico di Milano
  • MSc Bioengineering, University of Illinois at Chicago-USA
Laura Brolis linkedin Laura Brolis mail
Laura Brolis
Laura Brolis
  • Former CFO - DGPA SGR
  • DG - Albertini SGR
  • Operations manager - Dresdner Bank AG
  • Degree in economics at Università degli Studi di Bergamo
Paola Crovato linkedin Paola Crovato mail
Paola Crovato
Paola Crovato
Office & Deal Flow Manager
  • Office Manager at Pioneer Investment Management SGR
  • Degree in economics at Università del Sacro Cuore di Milano


  • Antonello Biscini

    Antonio Biscini VP Biz Dev MENARINI

    Antonio heads Business Development & Licensing at Menarini, the largest Italian pharmaceutical group with over 4.2b$ sales in 2013

  • Fabrizio Chines

    Fabrizio Chines Executive Chairman and CEO at SIFI S.p.A.

    Fabrizio has a strong experience in the opthalmic sector where SIFI is a worldwide leader

  • Cogliati Gabriele

    Gabriele Cogliati Founder and CEO ELEMASTER

    Gabriele has built and leads the Italian leader in designing and developing electronic technologies for command, control and regulation devices of medical use

  • Maurizio Colombo

    Maurizio Colombo Founder of Sapio Group and President of Sapio Life

    Maurizio is an entrepreneur at the forefront of the innovation in the sectors of gases and of the services related to Hospital and remote Patient Assistance.

  • Laura Iris Ferro

    Laura Iris Ferro Founder and former CEO GENTIUM

    Laura is a Successful entrepreneur who has built and sold Gentium, leader in the development and of active ingredients derived from natural sources as potential therapeutic agents, sold to Jazz Pharmaceuticals for 1b$ in 2013

  • Emanuele Gatti

    Emanuele Gatti Former CEO EMEA and Board Member FRESENIUS MEDICAL CARE

    Emanuele has a life-long experience in the dialysis and kidney failures business, serving for almost 20 years as top Executive and Board Member in Fresenius, a dialysis global leader

  • Emanuele Gatti

    Paola Ricciardi-Castagnoli World renown immunologist expert

    Paola is an Italian Immunologist presently Scientific Director of Toscana Life Sciences Foundation (TLS) in Siena and former Scientific Director and founder of the Singapore Immunology Network (SIgN), a research institute of the Agency for Science, Technology and Research. Between 1998 and 2010 Professor Ricciardi-Castagnoli was Chair of Immunology and General Pathology at the University of Milano-Bicocca.

  • Lucio Rovati

    Lucio Rovati Founder of Rottapharm and CEO / CSO of Rottapharm Biotech

    Lucio is a successful entrepreneur and experienced CSO, who has built Rottapharm, leader in research, development, manufacturing, global marketing and distribution of branded clinically proven consumer healthcare products, reimbursed prescription products and natural extracts.and of active ingredients derived from natural sources as potential therapeutic agents, sold to Meda for 3.1b$ in 2014


Industrial, Financial and Academic Partners




European Investment Fund & European Commission
Panakes is supported by the INNOVFIN SME Venture Capital with the financial backing of the European Union under Horizon 2020 Financial Instruments established under Regulation (No) 1291/2013 of the European Parliament and the Council establishing Horizon 2020 – the Framework Programme for Research and Innovation (2014-2020)][through financial backing of the European Union under the Equity Facility for Growth established under Regulation (EU) No 1287/2013 of the European Parliament and the Council establishing a Programme for the Competitiveness of Enterprises and small and medium enterprises (COSME) (2014-2020)


Portfolio Echographic approach for osteoporosis early diagnosis Bioabsorbable Percutaneous Closure Device for Large-Bore Transcatheter Procedures


Medical device and methodology for tumor treatment The world's first system that eliminates laparoscopic surgical smoke without the need for gas exchange Novel robotic solutions for unmet medical needs, specifically designed for open microsurgery

Aileens New wave of products for dermatological diseases

CarThera Innovative therapeutic ultrasound-based medical devices for treating brain tumors

EndoStart Endoscopic device to avoid incomplete colonoscopies

Diadem Blood test able to predict Alzheimer’s Disease (AD) onset in pre-symptomatic population

Samantree Breakthrough imaging solution that brings accurate and full margin control by the surgeon during breast cancer procedure.



Lausanne, Switzerland – May 6th, 2019

SamanTree Medical Raises CHF 9.5 Million to Assess the Margins in Cancer Surgery

Milan, Italy, December 21, 2018

Diadem, an academic spin-off active in early Alzheimer diagnostic, raises €1,5 million in its A Round led by Panakes Partners

Florence, Italy, December 20, 2018

Endostart, an Italian startup aiming at reducing endoscopic procedures’ complexity, raised €1 million in its seed round of financing

Paris, France, December 12, 2018

CarThera closes €9M ($10.3M) Series B funding round

Milan, Italy, 18 July 2018

Aileens Pharma S.r.l. Announces €3M in Series A Funding to advance the development of a wave of Innovative Non-Steroidal Treatments for Dermatologic disorders

Calci, Italy, 18 April 2018

Medical Microinstruments S.p.A. Announces €20M in Series A Funding to Advance its Robotic Platform for Microsurgery

Cardiff, Wales, 31 May 2017

Alesi Surgical raises €6m (£5.2m) to accelerate commercialisation of breakthrough product UltravisionTM

Galway, Ireland, 7 September 2016

Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States

Milan, 6 September 2016

Seventeen, a startup aiming to disrupt loco-regional therapies for solid tumors, raised a Series A for more than €4 million

Milan, 21 July 2016

Medtech Startup Echolight Raises €4M in Series A Funding

Milan, 8 march 2016

Panakès Partners SGR announces the arrival of Barbara CASTELLANO as part of the investment team

Milan, 15 February 2015

Partners SGR launches its first Venture Capital Fund dedicated to European Medtech startups.

Contact Us

  • twitter
  • linkedin
  • Panakes Partners Panakes Partners
    Via Boscovich 31
    20124 - Milano

  • To submit a deal To submit a deal
  • To Arrive To Arrive
    5 minutes from the central station
    20 minutes from Linate Airport